Recalled medical system may cause tears, bleeding in heart tissue

The TigerPaw II is a surgical staple used to close tissue in the left atrial appendage of the heart.

The FDA recalled the TigerPaw II by Maquet Medical Systems, because incomplete closure of the it may result in tissue tears and/or bleeding, including a possible tear on the left atrial wall during use of the device.

Maquet Medical Systems received 51 reports of adverse events and one death, according to the FDA.

The TigerPaw II is a surgical staple used to close tissue in the left atrial appendage of the heart.

The affected devices were distributed April 1, 2013 through March 23, 2015. 

 

 

Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026